IGTP in 2025: 12 selected news stories
We look back at the year's most significant news stories, showcasing the dedication and collaboration that define IGTP.
At the IGTP TODAY
News
Germans Trias Hospital launches the first screening program in Catalonia to detect type 1 diabetes before the onset of symptoms
Early diagnosis can help prevent serious complications, reduce hospital admissions and minimise the impact of disease onset in children and adolescents
_1766478647.jpeg)
A new study explores why the same mutation in the BRAF gene leads to different therapeutic responses to its inhibitors in melanoma and colorectal cancer
Researchers from the B·ARGO at IGTP and ICO have conducted a comparative analysis of the impact of BRAF gene mutations in melanoma and colorectal cancer, published in the journal BBA Reviews on Cancer.
IGTP secures over €13 million to support the development of research projects and strengthen research talent
The Germans Trias i Pujol Research Institute has secured €13,208,000 through several funding calls supporting research projects and research activity, the results of which were announced this December, including both Spanish and Catalan-level calls.
- Research
The antibiotic delafloxacin emerges as a potential therapeutic alternative against Legionella
A study led by IGTP researchers shows that, in a laboratory model, delafloxacin inhibits the intracellular replication of Legionella more effectively than a current standard treatment, supporting its potential therapeutic value and the need for future clinical studies.
- Research
Occupational factors strongly influence Long-COVID risk
Work-related factors play a significant and independent role in the risk of developing Long-COVID, shows a new study based on the COVICAT cohort and led by ISGlobal, in collaboration with the University of Turin and the IGTP. The findings, published in BMJ Occupational & Environmental Medicine, highlight that a substantial share of Long-COVID could be prevented through targeted workplace measures and policies.
IGTP celebrates 30 years of transforming knowledge into health
On 11 December, IGTP celebrated its 30th anniversary with an institutional and Christmas event that brought together professionals from across the Institute in a space for recognition, remembrance, and looking ahead to the future.
The CARE Annual Meeting reviews the program’s cancer research activity and sets priorities for the months ahead
The III CARE Annual Meeting, held on 5 December at BCIN, brought together the cancer research community of the Can Ruti Campus for a day focused on scientific dialogue, interdisciplinarity and future strategy.
IGTP drives collaborative science in health after three years of cooperation in biotechnology
The closing event celebrated on 17 November highlighted the work carried out and strengthened the commitment to maintain and expand the synergies created within the framework of the Plan. IGTP has contributed to several collaborative projects, focused on type 2 diabetes, breast cancer and medical databases.
- Research
New evidence on the therapeutic potential of extracellular vesicles in kidney injury
Researchers at IGTP have published an article analysing the therapeutic potential of extracellular vesicles derived from mesenchymal stem cells to address kidney injury, reviewing current evidence on how these vesicles can interact with renal tubular epithelial cells.
